Exudative retinal detachment in castleman disease

Gaetano R Barile1, Nora Khatib, Song Eun Lee

  • 1From the *Department of Ophthalmology, and †Department of Pathology, Columbia University Medical Center, New York, New York.

Insights

Castleman disease (CD) can cause visual symptoms like retinal detachments. Systemic treatment for CD led to the resolution of these retinal issues without local therapy, highlighting a key observation for managing this rare condition.

Area of Science:

  • Ophthalmology
  • Hematology
  • Oncology

Background:

  • Castleman disease (CD) is a rare lymphoproliferative disorder.
  • CD can present with diverse clinical manifestations, including ocular involvement.
  • Visual symptoms and retinal disease are uncommon but significant presentations of CD.

Purpose of the Study:

  • To document a case of Castleman disease presenting with visual disturbances.
  • To describe the ocular findings, specifically retinal disease, in a patient with CD.
  • To illustrate the management and outcome of retinal manifestations in CD.

Main Methods:

  • Comprehensive clinical examination and fundus photography.
  • Advanced imaging techniques including fluorescein and indocyanine green angiography.
  • Diagnostic workup involving CT scans, blood tests, lymph node biopsy, and renal biopsy.

Main Results:

  • A patient diagnosed with Castleman disease exhibited bilateral exudative retinal detachments.
  • Systemic treatment with steroids for CD was initiated.
  • Renal failure occurred during treatment but was successfully managed with plasmapheresis.
  • The exudative retinal detachments resolved spontaneously within four weeks of systemic treatment initiation, without local ocular intervention.

Conclusions:

  • Exudative retinal detachments can be a manifestation of Castleman disease.
  • Systemic treatment for Castleman disease may lead to the resolution of associated retinal detachments.
  • Observation of retinal changes under systemic therapy is a viable approach before considering local ocular treatments for CD-related retinal disease.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
11
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K